STOCK TITAN
  1. Home
  2. Sec-filings
  3. STOK
  4. [EFFECT] Stoke Therapeutics, Inc. SEC Filing

[EFFECT] Stoke Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001623526
Company Name: Stoke Therapeutics, Inc.
File Number: 333-288583

Source: View Original Filing on SEC EDGAR

Stock STOK logo
Stoke Therapeutics

NASDAQ:STOK

STOK Rankings

#2360 Ranked by Market Cap
N/A Ranked by Dividends

STOK Latest News

Jan 16, 2026
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jan 11, 2026
Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome
Jan 6, 2026
Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dec 16, 2025
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Dec 1, 2025
Stoke Therapeutics and Biogen Announce Presentations at the 2025 American Epilepsy Society Annual Meeting

STOK Latest SEC Filings

Jan 12, 2026
[8-K] Stoke Therapeutics, Inc. Reports Material Event
Dec 5, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Dec 5, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Nov 26, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Nov 18, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity

STOK Stock Data

1.72B
51.62M
4.46%
118.44%
19.6%
Biotechnology
Pharmaceutical Preparations
Link
United States
BEDFORD